Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

"Merck bought a company for their already successful antibiotic and the others they had in the pipeline" hardly undermines the notion that there's still money in antibiotic development.

And they're still funding studies for Fidaxomicin.



Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: